KA/EN
Register
Medicines reference
Search
Search
Product

Nobivac Tricat Trio

Favourites

Feline calicivirus + Feline herpesvirus + Feline parvovirus · Intervet International B.V.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Cat Cat 1 ml
Reconstitute with the supplied 1 ml solvent and inject one 1 ml dose subcutaneously. Give the first dose at 8-9 weeks and the second from 12 weeks. Revaccinate FCV/FVR annually and FPLV every 3 years. Maternal antibodies through 9-12 weeks may reduce efficacy. Vaccinate healthy cats only. Do not use during pregnancy or lactation. Transient local or respiratory/systemic reactions are described; hypersensitivity or anaphylaxis is very rare.
 · two-dose primary series, then revaccination according to the SPC schedule		 two-dose primary series, then revaccination according to the SPC schedule Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ნობივაკ ტრიქეთ ტრიო
№ 41-11; 256-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Nobivac Tricat Trio, Suspension

lyophilisate and solvent for injection, 1 ml dose for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.5/10
Very good
vetman assessment

Nobivac Tricat Trio

lyophilisate and solvent for injection, 1 ml dose for cats
Assessed clinical scopeCat · Full cat label: active immunisation against feline calicivirus, herpesvirus and panleucopenia with the labelled two-dose primary course and component-specific revaccination · Subcutaneous
Care settingPreventive feline vaccination with examination, cold-chain control, injection-site planning and emergency treatment available
vetman score 8.5/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 41-11; 256-11 · Verified on 21 Oct 2026

A well-supported live feline core vaccine with clear component-specific durations. Its main limits are the non-sterilising nature of respiratory-virus protection and the need to adapt the kitten series when maternal antibody may outlast the label minimum.

Regulatory and scientific credibility9.0/10

The exact presentation is registered in Georgia and supported by a current SPC and regulator assessment documenting strains, quality, challenge efficacy, onset, duration and adverse reactions.

Clinical efficacy8.3/10

All three antigens are global feline core targets. Panleucopenia protection is strong and long-lived; FCV and FHV vaccination meaningfully reduces disease but not all infection or shedding, and the label course ending from 12 weeks may need extension through at least 16 weeks when maternal antibody persists.

Safety and tolerability8.2/10

The live attenuated vaccine has a favourable profile in healthy cats, with mostly transient local, respiratory or systemic reactions; very rare anaphylaxis remains important and pregnancy or lactation use is contraindicated.

Clinical practicality8.2/10

A fixed 1 ml SC dose, one reconstitution step and three-year FPLV interval are practical; annual FCV/FHV revaccination, cold chain and age-appropriate kitten-series planning remain recurring work.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Vaccinate healthy cats only; do not use in hypersensitivity to a component.
  • Do not use during pregnancy or lactation.
  • Maternal antibodies can interfere through 9-12 weeks; plan a final core dose at 16 weeks or later when risk persists.
  • FCV and FHV vaccination reduces disease but does not reliably prevent every infection, carrier state or episode of shedding.
  • Very rare hypersensitivity or anaphylaxis requires immediate treatment; monitor local, respiratory and systemic reactions.
  • Do not mix with other veterinary medicines unless the exact combination is authorised; assess same-day use individually.
  • Maintain the cold chain, reconstitute only with the supplied solvent and use the full 1 ml dose promptly; do not freeze.
Assessment sources
  1. VMD SPC 20242024
  2. Tricat public assessment2026
  3. WSAVA vaccination 20242024
  4. AAHA/AAFP feline vaccination 20202020
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Feline calicivirus4.6 log10 PFU/dose Feline herpesvirus5.2 log10 PFU/dose Feline parvovirus4.3 log10 CCID50/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Intervet International B.V. · Netherlands
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ნობივაკ ტრიქეთ ტრიო
№ 41-11; 256-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml
Reconstitute with the supplied 1 ml solvent and inject one 1 ml dose subcutaneously. Give the first dose at 8-9 weeks and the second from 12 weeks. Revaccinate FCV/FVR annually and FPLV every 3 years. Maternal antibodies through 9-12 weeks may reduce efficacy. Vaccinate healthy cats only. Do not use during pregnancy or lactation. Transient local or respiratory/systemic reactions are described; hypersensitivity or anaphylaxis is very rare.
 Cat Any weight Subcutaneous two-dose primary series, then revaccination according to the SPC schedule
VMD SPC 2024
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Nobivac Tricat Trio - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024

Feline calicivirus: No dose supported by a publicly verifiable source yet

Feline herpesvirus: No dose supported by a publicly verifiable source yet

Feline parvovirus: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (3 more) Hide additional products

Same active ingredients 3

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗